References

Ajani, J.A., V.M. Moiseyenko, S. Tjulandin, A. Majlis and M. Constenla et al., 2007. Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal adenocarcinoma: The V-325 sudy group. J. Clin. Oncol., 25: 3205-3209.
CrossRef  |  PubMed  |  Direct Link  |  

Argiles, J., 2005. Cancer-associated malnutrition. Eur. J. Oncol. Nurs., 9: S39-S50.
CrossRef  |  PubMed  |  

Barber, M.D. and K.C.H. Fearon, 2001. Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia. Lipids, 36: 347-351.
CrossRef  |  

Barber, M.D., J.A. Ross, T. Preston, A. Shenkin and K.C.H. Fearon, 1999. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J. Nutr., 129: 1120-1125.
Direct Link  |  

Bruera, E., 1997. ABC of palliative care: Anorexia, cachexia and nutrition. Biomed. J., 315: 1219-1219.
Direct Link  |  

Cohn, S.H., W. Gartenhaus, D. Vartsky, A. Sawitsky and I. Zanzi et al., 1981. Body composition and dietary intake in neoplasic disease. Am. J. Clin. Nutr., 341: 1997-2004.
PubMed  |  

De la Puerta, R., A. Marquez-Martin, A. Fernandez-Arche and V. Ruiz-Gutierrez, 2009. Influence of dietary fat on oxidative stress and inflammation in murine macrophages. Nutrition, 25: 548-554.
CrossRef  |  

Fearon, K.C., A.C. Voss and D.S. Hustead, 2006. Definition of cancer cachexia: Effect of weight loss, reduced food intake and systemic inflammation on functional status and prognosis. Am. J. Clin. Nutr., 83: 1345-1350.
Direct Link  |  

Ferlay, J., H.R. Shin, F. Bray, D. Forman, C. Mathers and D.M. Parkin, 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127: 2893-2917.
CrossRef  |  Direct Link  |  

Giacosa, A. and M. Rondanelli, 2008. Fish oil and treatment of cancer cachexia. Genes Nutr., 3: 25-28.
CrossRef  |  

Grimble, R.E., 2003. Nutritional therapy for cancer cachexia. Gut, 52: 1391-1392.
PubMed  |  

Grimm, H., N. Mertes, C. Goeters, E. Schlotzer, K. Mayer, F. Grimminger and P. Furst, 2006. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur. J. Nutr., 45: 55-60.
CrossRef  |  Direct Link  |  

Ilhan, N., N. Iihan, Y. Ilhan, H. Akbulut and M. Kucuksu, 2004. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J. Gastroenterol., 10: 1115-1120.
PubMed  |  

Kapoor, S., 2009. Immunomodulatory properties of omega-3 fatty acids: A possible explanation for their systemic, anti-carcinogenic effects. J. Leukocyte Biol., 85: 2-3.
PubMed  |  

Levine, J.A. and M.Y. Morgan, 1998. Preservation of macronutrient preferences in cancer anorexia. Br. J. Cancer, 78: 579-581.
PubMed  |  

Mantovani, G., A. Maccio, L. Mura, E. Massa and M.C. Mudu et al., 2000. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J. Mol. Med., 78: 554-561.
PubMed  |  

Mantovani, G., C. Madeddu, A. Maccio, G. Gramignano and M.R. Lusso et al., 2004. Cancer-related anorexia/cachexia syndrome and oxidative stress: An innovative approach beyond current treatment. Cancer Epidemiol. Biomarkers Prev., 13: 1651-1659.
PubMed  |  

Mori, T.A., R.J. Woodman, V. Burke, I.B. Puddey, K.D. Croft and L.J. Beilin, 2003. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radical Biol. Med., 35: 772-781.
PubMed  |  

Naghavi, M., 2005. Iranian annual of national death registration report. Iran Ministry of Health and Medical Education.

Parkinson, S.A., J. Lewis, R. Morris, A. Allbright, H. Plant and M.L. Slevin, 1987. Oral protein and energy supplements in cancer patients. Hum. Nutr. Applied Nutr., 41: 233-243.
PubMed  |  

Plata-Salaman, C.R., 2000. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition, 16: 1009-1012.
PubMed  |  

Preston, T., C. Slater, D.C. McMillan, J.S. Falconer, A. Shenkin and K.C.H. Fearon, 1998. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J. Nutr., 128: 1355-1360.
Direct Link  |  

Rafiei, M., M. Boshtam, A. Marandi, A. Jalali and R. Vakili, 2003. The Iranian Food Consumption Program (IFCP), a unique nutritional software in Iran. Iran. J. Publ. Health, 31: 105-107.
Direct Link  |  

Sadjadi, A., M. Nouraie, M.A. Mohagheghi, A. Mousavi-Jarrahi, R. Malekezadeh and D.M. Parkin, 2002. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac. J. Cancer Prev., 6: 359-363.
Direct Link  |  

Sadjadi, A., R. Malekzadeh, M.H. Derakhshan, A. Sepehr and M. Nouraie et al., 2003. Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int. J. Cancer, 107: 113-118.
PubMed  |  

Simons, J.P.F.H.A., A.M.W. J. Schols, J.M.J. Hoefnagels, K.R. Westerterp, G.P.M. Velde and E.F.M. Wouters, 1998. Effects of medroxyprogesterone acetate on food intake, body composition and resting energy expenditure in patients with advanced, nonhormone sensitive cancer. Cancer, 82: 553-560.
CrossRef  |  

Simopoulos, A.P., 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr., 21: 499-505.
Direct Link  |  

Staal-van den Brekel, A.J., A.M. Schols, G.P. ten Velde, W.A. Buurman and E.F. Wouters, 1994. Analysis of the energy balance in lung cancer patients. Cancer Res., 54: 6430-6433.
Direct Link  |  

Vega-Lopez, S., N. Kaul, S. Devaraj, R.Y. Cai, B. German and I. Jialal, 2004. Supplementation with ω3 polyunsaturated fatty acids and all-rac α-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism, 53: 236-240.
CrossRef  |  

Wigmore, S.J., C.E. Plester, J.A. Ross and K.C.H. Fearon, 1997. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br. J. Surg., 84: 196-197.
CrossRef  |  

Wigmore, S.J., M.D. Barber, J.A. Ross, M.J. Tisdale and K.C. Fearon, 2000. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr. Cancer, 36: 177-184.
PubMed  |  

Wigmore, S.J., P.T. Todorov, M.D. Barber, J.A. Ross, M.J. Tisdale and K.C.H. Fearon, 2000. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor. Br. J. Surg., 87: 53-58.
CrossRef  |  

Yu, J.H., S.G. Kang, U.Y. Jung, C.H. Jun and H. Kim, 2009. Effects of omega-3-fatty acids on apoptosis of human gastric epithelial cells exposed to silica immobilized glucose oxidase. Ann. N.Y. Acad. Sci., 1171: 359-364.
CrossRef  |  

Ziegler, R.G., 1989. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J. Nutr., 119: 116-122.
PubMed  |